Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

32.43
-0.0289-0.09%
Post-market: 32.450.0189+0.06%19:30 EDT
Volume:4K
Turnover:120.89K
Market Cap:41.35M
PE:- -
High:32.54
Open:32.54
Low:32.29
Close:32.46
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:1.09
T/O Rate:0.29%
Dividend:0.08
Dividend Rate:0.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Sep 29

Market Chatter: Eli Lilly CEO Plans Larger Deals to Target New Disease Areas

MT Newswires Live
·
Sep 29

Lilly CEO Eyes Bigger Deals in Hunt for Pharma's 'white Spaces' - Bloomberg News

Reuters
·
Sep 29

Eli Lilly CEO tells Bloomberg sees more deals in untapped areas

TIPRANKS
·
Sep 29

Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study

Reuters
·
Sep 28

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Taking Ozempic? a Routine Eye Exam Could Help You Understand Your Risk for Vision Loss

Dow Jones
·
Sep 28

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ascendis Pharma (ASND), Lakefront Biotherapeutics (LKFT) and 10x Genomics (TXG)

TIPRANKS
·
Sep 28

Eli Lilly price target raised to $1,500 from $1,400 at JPMorgan

TIPRANKS
·
Sep 28

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Reuters
·
Sep 28

Lilly Launches Initiative to Expand Diabetes, Obesity Drug Access

MT Newswires Live
·
Sep 28

Eli Lilly launches ‘Lilly Change the Course Commitment’

TIPRANKS
·
Sep 28

Eli Lilly - to Register Diabetes and Obesity Medicines in Lmics and Expand Access

THOMSON REUTERS
·
Sep 28

Eli Lilly - Aims to Treat Equal Number of Patients in Lmics and High-Income Countries by 2040

THOMSON REUTERS
·
Sep 28

Zymeworks sees FY26 revenue $278M-$292M, consensus $304.04M

TIPRANKS
·
Sep 28

Ascendis Pharma Price Target Maintained with a $300.00/Share by Cantor Fitzgerald

Dow Jones
·
Sep 28

JPMorgan Adjusts Price Target on Eli Lilly to $1,500 From $1,400, Maintains Overweight Rating

MT Newswires Live
·
Sep 28

Eli Lilly's Olumiant Gets FDA Approval for Severe Alopecia Areata in Adolescents

MT Newswires Live
·
Sep 28

EBR Systems advances FDA approval process for new WiSE manufacturing site

TIPRANKS
·
Sep 28

Nektar selloff on trial brings ‘strong entry point,’ says BTIG

TIPRANKS
·
Sep 28